Annexin-directed β-glucuronidase for the targeted treatment of solid tumors.

Abstract excerpt

Enzyme prodrug therapy has the potential to remedy the lack of selectivity associated with the systemic administration of chemotherapy. However, most current systems are immunogenic and constrained to a monotherapeutic approach. We developed a new class of fusion proteins centered about the human enzyme β-glucuronidase (βG), capable of converting several innocuous prodrugs into chemotherapeutics. We targeted βG...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Annexin A5
• Share to Glucuronidase
• Share to Hydrogen-Ion Concentration